Tiziana Life Sciences plc: Total Voting Rights
July 31, 2020 12:00 ET
|
Tiziana Life Sciences Plc
LONDON and NEW YORK, July 31, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the "Company" or "Tiziana"), a US and UK biotechnology company that focuses on the...
Tiziana Life Sciences plc: Tiziana Announces Submission of a Patent Application for Nasal Administration of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, for Treatment of COVID-19 Patients
July 31, 2020 02:00 ET
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, July 31, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics...
Tiziana Life Sciences plc: Early notification of proposed admission to the Official List and cancellation of trading on AIM
July 30, 2020 11:31 ET
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, July 30, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc the dual listed (NASDAQ:TLSA & UK AIMS:TILS) today announces its intention to apply for admission to listing of...
Tiziana Life Sciences to Participate in Investor Webinar to Provide Corporate Updates and Q&A Session on July 30, 2020
July 30, 2020 02:00 ET
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, July 30, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics...
Exercise of Warrants and Issue of Equity and Total Voting Rights
July 24, 2020 02:00 ET
|
Tiziana Life Sciences Plc
LONDON and NEW YORK, July 24, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics...
Tiziana Life Sciences plc ("Tiziana" or the "Company") Director Appointment
July 20, 2020 10:17 ET
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, July 20, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a US and UK biotechnology company that focuses on the discovery and development of novel...
Results of Annual General Meeting
July 16, 2020 07:23 ET
|
Tiziana Life Sciences Plc
LONDON and NEW YORK, July 16, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (the "Company" or "Tiziana"), a US and UK biotechnology company that focuses on the...
Tiziana Announces Submission of Patent Application on Use of Foralumab, the Only Fully Human Anti-CD3 Monoclonal Antibody, to Enhance Success of CAR-T Therapy
July 16, 2020 02:00 ET
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, July 16, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) (“Tiziana” or the “Company”), a biotechnology company focused on innovative therapeutics...
Tiziana Life Sciences plc Change to ADS Ratio - Updated
July 15, 2020 11:55 ET
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, July 15, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc ("Tiziana", AIM: TILS, NASDAQ: TLSA), announces a ratio change to its sponsored Level 3 American Depositary Receipt...
Tiziana Life Sciences plc Change to ADS Ratio
July 15, 2020 08:28 ET
|
Tiziana Life Sciences Plc
NEW YORK and LONDON, July 15, 2020 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc ("Tiziana", AIM: TILS, NASDAQ: TLSA), announces a ratio change to its sponsored Level 3 American Depositary Receipt...